Rich Prest
@richardprest
bio and health, US commercialization, product, strategy, and growth richreads.substack.com
ID: 15830475
13-08-2008 00:28:18
2,2K Tweet
871 Followers
728 Following
Promising results from SGLT2 inhibitors reducing NSCLC mortality. More than glycemic control: sodium-glucose cotransporter inhibitors may extend lung cancer survival Peter Attia buff.ly/3ZepYTA